Pieris Pharmaceuticals (PIRS) PT Lowered to $5 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts PIRS Hot Sheet
Price: $13.60 --0%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 12 | New: 7
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 12 | New: 7
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Pieris Pharmaceuticals (NASDAQ: PIRS) to $5.00 (from $12.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zymeworks (ZYME) PT Raised to $55 at H.C. Wainwright
- Jiangsu Hengli Hydraulic Co Ltd (601100:CH) PT Raised to RMB137.60 at Macquarie
- Regenxbio Inc. (RGNX) PT Lowered to $21 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
